123 related articles for article (PubMed ID: 18769130)
1. Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.
Lee JS; Fackler MJ; Teo WW; Lee JH; Choi C; Park MH; Yoon JH; Zhang Z; Argani P; Sukumar S
Cancer Biol Ther; 2008 Sep; 7(9):1398-406. PubMed ID: 18769130
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.
Kim JH; Shin MH; Kweon SS; Park MH; Yoon JH; Lee JS; Choi C; Fackler MJ; Sukumar S
Gynecol Oncol; 2010 Aug; 118(2):176-81. PubMed ID: 20466412
[TBL] [Abstract][Full Text] [Related]
3. Promoter CpG island hypermethylation during breast cancer progression.
Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.
Fackler MJ; McVeigh M; Evron E; Garrett E; Mehrotra J; Polyak K; Sukumar S; Argani P
Int J Cancer; 2003 Dec; 107(6):970-5. PubMed ID: 14601057
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.
Mao X; Qiao Z; Fan C; Guo A; Yu X; Jin F
Oncol Rep; 2016 Oct; 36(4):1868-74. PubMed ID: 27498697
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
Verschuur-Maes AH; de Bruin PC; van Diest PJ
Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge.
Fackler MJ; Rivers A; Teo WW; Mangat A; Taylor E; Zhang Z; Goodman S; Argani P; Nayar R; Susnik B; Sukumar S; Khan SA
Clin Cancer Res; 2009 Jun; 15(11):3802-11. PubMed ID: 19470737
[TBL] [Abstract][Full Text] [Related]
8. Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.
Pang JM; Deb S; Takano EA; Byrne DJ; Jene N; Boulghourjian A; Holliday A; Millar E; Lee CS; O'Toole SA; Dobrovic A; Fox SB
Breast Cancer Res; 2014 Oct; 16(5):423. PubMed ID: 25331261
[TBL] [Abstract][Full Text] [Related]
9. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women.
Lee JS; Lo PK; Fackler MJ; Argani P; Zhang Z; Garrett-Meyer E; Sukumar S
Cancer Biol Ther; 2007 Jul; 6(7):1114-20. PubMed ID: 17611401
[TBL] [Abstract][Full Text] [Related]
12. CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma in situ.
Guvakova MA; Prabakaran I; Wu Z; Hoffman DI; Huang Y; Tchou J; Zhang PJ
Breast Cancer Res Treat; 2020 Sep; 183(2):333-346. PubMed ID: 32683564
[TBL] [Abstract][Full Text] [Related]
13. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F
Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916
[TBL] [Abstract][Full Text] [Related]
14. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer.
Fackler MJ; McVeigh M; Mehrotra J; Blum MA; Lange J; Lapides A; Garrett E; Argani P; Sukumar S
Cancer Res; 2004 Jul; 64(13):4442-52. PubMed ID: 15231653
[TBL] [Abstract][Full Text] [Related]
15. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
[TBL] [Abstract][Full Text] [Related]
16. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
17. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
Abba MC; Gong T; Lu Y; Lee J; Zhong Y; Lacunza E; Butti M; Takata Y; Gaddis S; Shen J; Estecio MR; Sahin AA; Aldaz CM
Cancer Res; 2015 Sep; 75(18):3980-90. PubMed ID: 26249178
[TBL] [Abstract][Full Text] [Related]
18. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
Moelans CB; Verschuur-Maes AH; van Diest PJ
J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
[TBL] [Abstract][Full Text] [Related]
19. Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.
Kim GE; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Virchows Arch; 2011 Oct; 459(4):383-90. PubMed ID: 21894562
[TBL] [Abstract][Full Text] [Related]
20. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
